Bay Street News

CTS Announces Fourth Quarter and Full-Year 2023 Results

Building Momentum on Long-term Strategy While Navigating Near-term Challenges
Announces $100 million Share Repurchase Program

LISLE, Ill., Feb. 06, 2024 (GLOBE NEWSWIRE) — CTS Corporation (NYSE: CTS), a leading global designer and manufacturer of custom engineered solutions that “Sense, Connect and Move,” today announced fourth quarter and full-year 2023 results.

“We made good progress in 2023 on our strategic priorities, adding content through several new products in transportation and achieving strong electrification awards. We continued to win new customers and applications in the non-transportation end markets that will support our long-term goal to further diversify and strengthen our business,” said Kieran O’Sullivan, CEO of CTS Corporation. “Our teams managed through a challenging year largely driven by headwinds in the industrial and distribution end-market as well as softening sales of commercial vehicle related products. Growth was solid in medical, and aerospace and defense end-markets. We continue to focus on operational improvements and prudent cost management in this environment. Looking ahead, we expect a soft first half, and an improving trend in the second half of 2024.”

CTS also announced that its Board of Directors approved a new share repurchase program that authorizes the company to repurchase up to $100 million of its common stock, replacing the existing program authorized in February 2023. The new share repurchase program has no scheduled termination date.

Fourth Quarter 2023 Results

Full-Year 2023 Results

2024 Guidance

CTS expects full-year 2024 sales to be in the range of $530 – $570 million and adjusted diluted EPS to be in the range of $2.10 – $2.35.

CTS does not provide reconciliations of forward-looking non-GAAP financial measures, such as estimated adjusted diluted earnings per share, to the most comparable GAAP financial measures on a forward-looking basis because CTS is unable to provide a meaningful or accurate calculation or estimation of reconciling items and the information is not available without unreasonable effort. This is due to the inherent difficulty of forecasting the timing and amount of certain items, such as, but not limited to, restructuring costs, environmental remediation costs, acquisition-related costs, foreign exchange rates and other non-routine costs. Each of such adjustments has not yet occurred, are out of CTS’ control and/or cannot be reasonably predicted. For the same reasons, CTS is unable to address the probable significance of the unavailable information.

Conference Call and Supplemental Materials

As previously announced, the Company has scheduled a conference call for 10:00 a.m. (EST) today. The dial-in number for the U.S. and Canada is 844-200-6205 (+1 929-526-1599, if calling from outside the U.S. and Canada). The passcode is 889906. In addition, the Company will be using a supplemental slide presentation that will be referred to during the call. The presentation and a live audio webcast of the conference call will be available and can be accessed directly from CTS’ website at https://www.ctscorp.com/investors/events-presentations/.

About CTS

CTS Corporation (NYSE: CTS) is a leading designer and manufacturer of products that Sense, Connect and Move. CTS manufactures sensors, actuators and electronic components in North America, Europe and Asia, and provides engineered products to customers in the aerospace/defense, industrial, medical and transportation markets. For more information, visit www.ctscorp.com.

Safe Harbor

This document contains statements that are, or may be deemed to be, forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These forward-looking statements include, but are not limited to, any financial or other guidance, statements that reflect our current expectations concerning future results and events, and any other statements that are not based solely on historical fact. Forward-looking statements are based on management’s expectations, certain assumptions, and currently available information. Readers are cautioned not to place undue reliance on these forward-looking statements, which speak only as of the date hereof and are based on various assumptions as to future events, the occurrence of which necessarily are subject to uncertainties. These forward-looking statements are made subject to certain risks, uncertainties, and other factors, which could cause CTS’ actual results, performance, or achievements to differ materially from those presented in the forward-looking statements. Examples of factors that may affect future operating results and financial condition include, but are not limited to: supply chain disruptions; changes in the economy generally, including inflationary and/or recessionary conditions, and in respect to the business in which CTS operates; unanticipated issues in integrating acquisitions; the results of actions to reposition CTS’ business; rapid technological change; general market conditions in the transportation, as well as conditions in the industrial, aerospace and defense, and medical markets; reliance on key customers; unanticipated public health crises, natural disasters or other events; environmental compliance and remediation expenses; the ability to protect CTS’ intellectual property; pricing pressures and demand for CTS’ products; risks associated with CTS’ international operations, including trade and tariff barriers, exchange rates and political and geopolitical risks (including, without limitation, the potential impact U.S./China relations and the conflict between Russia and Ukraine may have on our business, results of operations and financial condition); the amount and timing of any share repurchases; and the effect of any cybersecurity incidents on our business. Many of these, and other risks and uncertainties, are discussed in further detail in Item 1A. of CTS’ most recent Annual Report on Form 10-K and other filings made with the SEC. CTS undertakes no obligation to publicly update CTS’ forward-looking statements to reflect new information or events or circumstances that arise after the date hereof, including market or industry changes. 

Contact 
Ashish Agrawal 
Vice President and Chief Financial Officer 
CTS Corporation 
4925 Indiana Avenue 
Lisle, IL 60532 USA 
+1 (630) 577-8800 
ashish.agrawal@ctscorp.com

CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED STATEMENTS OF EARNINGS – UNAUDITED
(In thousands, except per share amounts)
 
    Three Months Ended     Twelve Months Ended  
    December 31,
2023
    December 31,
2022
    December 31,
2023
    December 31,
2022
 
Net sales   $ 124,694     $ 142,281     $ 550,422     $ 586,869  
Cost of goods sold     82,630       91,277       359,563       376,331  
Gross margin     42,064       51,004       190,859       210,538  
Selling, general and administrative expenses     19,477       23,491       83,816       91,520  
Research and development expenses     5,290       5,405       24,918       24,100  
Restructuring charges     1,041       478       7,074       1,912  
Operating earnings     16,256       21,630       75,051       93,006  
Other (expense) income:                        
Interest expense     (822 )     (702 )     (3,331 )     (2,192 )
Interest income     1,538       716       4,625       1,326  
Other income (expense), net     655       (873 )     (1,192 )     (11,403 )
Total other income (expense), net     1,371       (859 )     102       (12,269 )
Earnings before income taxes     17,627       20,771       75,153       80,737  
Income tax expense     2,307       5,831       14,621       21,162  
Net earnings   $ 15,320     $ 14,940     $ 60,532     $ 59,575  
Earnings per share:                        
Basic   $ 0.49     $ 0.47     $ 1.93     $ 1.86  
Diluted   $ 0.49     $ 0.47     $ 1.92     $ 1.85  
Basic weighted – average common shares outstanding:     31,020       31,818       31,359       31,968  
Effect of dilutive securities     219       224       220       270  
Diluted weighted – average common shares outstanding:     31,239       32,042       31,579       32,238  
Cash dividends declared per share   $ 0.04     $ 0.04     $ 0.16     $ 0.16  
CTS CORPORATION AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE SHEETS
(In thousands of dollars)
 
    (Unaudited)
December 31, 2023
    December 31, 2022  
ASSETS            
Current Assets            
Cash and cash equivalents   $ 163,876     $ 156,910  
Accounts receivable, net     78,569       90,935  
Inventories, net     60,031       62,260  
Other current assets     16,873       15,655  
Total current assets     319,349       325,760  
Property, plant and equipment, net     92,592       97,300  
Operating lease assets, net     26,425       22,702  
Other Assets            
Goodwill     157,638       152,361  
Other intangible assets, net     103,957       108,053  
Deferred income taxes     25,183       23,461  
Other     16,023       18,850  
Total other assets     302,801       302,725  
Total Assets   $ 741,167     $ 748,487  
LIABILITIES AND SHAREHOLDERS’ EQUITY            
Current Liabilities            
Accounts payable   $ 43,499     $ 53,211  
Accrued payroll and benefits     14,585       20,063  
Operating lease obligations     4,394       3,936  
Accrued expenses and other liabilities     34,561       35,322  
Total current liabilities     97,039       112,532  
Long-term debt     67,500       83,670  
Long-term operating lease obligations     24,965       21,754  
Long-term pension obligations     4,655       5,048  
Deferred income taxes     14,729       16,010  
Other long-term obligations     5,457       3,249  
Total Liabilities     214,345       242,263  
Commitments and Contingencies            
Shareholders’ Equity            
Common stock     319,269       316,803  
Additional contributed capital     45,097       46,144  
Retained earnings     602,232       546,703  
Accumulated other comprehensive loss     4,264       (671 )
Total shareholders’ equity before treasury stock     970,862       908,979  
Treasury stock     (444,040 )     (402,755 )
Total shareholders’ equity     526,822       506,224  
Total Liabilities and Shareholders’ Equity   $ 741,167     $ 748,487  

CTS CORPORATION AND SUBSIDIARIES
OTHER SUPPLEMENTAL INFORMATION – UNAUDITED
(In millions of dollars, except percentages and per share amounts)

Non-GAAP Financial Measures

From time to time, CTS may use non-GAAP financial measures in discussing CTS’ business. These measures are intended to supplement, not replace, CTS’ presentation of its financial results in accordance with U.S. GAAP. CTS believes that the non-GAAP financial measures presented are commonly used by financial analysts and others in the industries in which CTS operates, and thus further provide useful information to investors. CTS’ definitions of these non-GAAP financial measures may differ from those terms as defined or used by other companies. Non-GAAP measures should not be used by investors or third parties as the sole basis for formulating investment decisions, as they may exclude a number of important cash and non-cash recurring items.

CTS has presented these non-GAAP financial measures as it believes that the presentation of its financial results that exclude (1) restructuring charges; (2) restructuring-related charges; (3) environmental charges; (4) acquisition-related costs; (5) inventory fair value step-up costs; (6) foreign exchange (gains) losses; (7) non-cash pension expenses (income); and (8) certain discrete tax items are useful and assist in comparing CTS’ current operating results with past periods and with the operational performance of other companies in its industry. Included below is a description of the expenses that CTS has determined are not normal, recurring cash operating expenses necessary to operate its business and the rationale for why providing financial measures for its business with such expenses excluded or adjusted is useful to investors as a supplement to the U.S. GAAP measures.

At times, the reconciliations below have been intentionally rounded to the nearest thousand, or $0.01 for EPS figures, and, therefore, may not sum.

Adjusted Gross Margin

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Gross margin   $ 42.1     $ 51.0     $ 190.9     $ 210.5     $ 184.6  
                               
Net sales   $ 124.7     $ 142.3     $ 550.4     $ 586.9     $ 512.9  
                               
Gross margin as a % of net sales     33.7 %     35.8 %     34.7 %     35.9 %     36.0 %
                               
Adjustments to reported gross margin:                              
Restructuring related charges (b)     0.6             0.6              
Inventory fair value step-up (b)           0.7             4.0        
                               
Adjusted gross margin   $ 42.6     $ 51.7     $ 191.4     $ 214.5     $ 184.6  
                               
Adjusted gross margin as a % of net sales     34.2 %     36.3 %     34.8 %     36.5 %     36.0 %

Adjusted Operating Earnings

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Operating earnings   $ 16.3     $ 21.6     $ 75.1     $ 93.0     $ 76.5  
                               
Net sales   $ 124.7     $ 142.3     $ 550.4     $ 586.9     $ 512.9  
                               
Operating earnings as a % of net sales     13.0 %     15.2 %     13.6 %     15.8 %     14.9 %
                               
Adjustments to reported operating earnings:                              
Restructuring charges (c)     1.0       0.5       7.1       1.9       1.7  
Restructuring related charges (b)     0.6             0.6              
Environmental charges (a)     0.4       1.0       3.5       2.8       2.3  
Acquisition-related costs (a)     0.2             0.4       0.8        
Inventory fair value step-up (b)           0.7             4.0        
Total adjustments to reported operating earnings   $ 2.2     $ 2.2     $ 11.5     $ 9.5     $ 3.9  
                               
Adjusted operating earnings   $ 18.4     $ 23.8     $ 86.6     $ 102.5     $ 80.4  
                               
Adjusted operating earnings as a % of net sales     14.8 %     16.7 %     15.7 %     17.5 %     15.7 %

Adjusted EBITDA Margin

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Net earnings (loss)   $ 15.3     $ 14.9     $ 60.5     $ 59.6     $ (41.9 )
                               
Net sales   $ 124.7     $ 142.3     $ 550.4     $ 586.9     $ 512.9  
                               
Net earnings (loss) margin     12.3 %     10.5 %     11.0 %     10.2 %     -8.2 %
                               
Depreciation and amortization expense     7.3       8.0       28.7       29.8       26.9  
Interest expense     0.8       0.7       3.3       2.2       2.1  
Tax expense (benefit)     2.3       5.8       14.6       21.2       (19.0 )
                               
EBITDA     25.7       29.5       107.2       112.7       (31.8 )
                               
Adjustments to EBITDA:                              
Restructuring charges (c)     1.0       0.5       7.1       1.9       1.7  
Restructuring related charges (b)     0.6             0.6              
Environmental charges (a)     0.4       1.0       3.5       2.8       2.3  
Acquisition-related costs (a)     0.2             0.4       2.5        
Inventory fair value step-up (b)           0.7             4.0        
Non-cash pension and related expense (d)                       4.8       132.4  
Foreign currency (gain) loss (d)     (0.3 )     0.9       2.0       4.9       3.3  
                               
Total adjustments to EBITDA     1.8       3.1       13.5       20.9       139.7  
                               
Adjusted EBITDA   $ 27.6     $ 32.6     $ 120.7     $ 133.6     $ 107.9  
                               
Adjusted EBITDA Margin     22.1 %     22.9 %     21.9 %     22.8 %     21.0 %

Adjusted Net Earnings and Adjusted Diluted Earnings Per Share

    Three Months Ended
December 31,

 
    2023     2023     2022     2022  
          Per share           Per share  
Net earnings (A)   $ 15.3     $ 0.49     $ 14.9     $ 0.47  
                         
Adjustments to reported net earnings:                        
Restructuring charges (c)     1.0       0.03       0.5       0.01  
Restructuring related charges (a)     0.6       0.02              
Environmental charges (a)     0.4       0.01       1.0       0.03  
Acquisition-related costs (a)     0.2       0.01              
Inventory fair value step-up (b)                 0.7       0.02  
Foreign currency (gain) loss (d)     (0.3 )     (0.01 )     0.9       0.03  
Total pretax adjustments to reported net earnings   $ 1.8     $ 0.06     $ 3.1     $ 0.10  
Income tax effect of above adjustments (f)     (0.8 )     (0.03 )     (0.4 )     (0.01 )
Total adjustments, tax affected (f) (B)   $ 1.0     $ 0.03     $ 2.6     $ 0.08  
                         
Tax adjustments:                        
Other discrete tax items (e)     (1.6 )     (0.05 )     0.2       0.01  
Total tax adjustments (C)   $ (1.6 )   $ (0.05 )   $ 0.2     $ 0.01  
Adjusted net earnings (A+B+C) and Adjusted net earnings per share   $ 14.7     $ 0.47     $ 17.8       0.56  
                         
Net sales   $ 124.7           $ 142.3        
                         
Net earnings as a % of net sales     12.3 %           10.5 %      
                         
Adjusted net earnings as a % of net sales     11.8 %           12.5 %      
    Twelve Months Ended
December 31,
 
    2023     2023     2022     2022     2021     2021  
          Per share           Per share           Per share  
Net earnings (loss) (A)   $ 60.5     $ 1.92     $ 59.6     $ 1.85     $ (41.9 )   $ (1.30 )
                                     
Adjustments to reported net earnings (loss):                                    
Restructuring charges (c)     7.1       0.22       1.9       0.06       1.7       0.06  
Restructuring related charges (a)     0.6       0.02                          
Environmental charges (a)     3.5       0.11       2.8       0.09       2.3       0.07  
Acquisition-related costs (a)     0.4       0.01       2.5       0.08              
Inventory fair value step-up (b)                 4.0       0.12              
Non-cash pension and related expense (d)                 4.8       0.15       132.4       4.10  
Foreign currency loss (d)     2.0       0.06       4.9       0.15       3.3       0.10  
Total pretax adjustments to reported net earnings (loss)   $ 13.5     $ 0.42     $ 20.9     $ 0.65     $ 139.7     $ 4.33  
Income tax effect of above adjustments (f)     (2.4 )     (0.07 )     (1.6 )     (0.05 )     (31.1 )     (0.99 )
Total adjustments, tax affected (f) (B)   $ 11.1     $ 0.35     $ 19.3     $ 0.60     $ 108.6     $ 3.34  
                                     
Tax adjustments:                                    
Increase in valuation allowances (e)                             0.9       0.03  
Other discrete tax items (e)     (1.6 )     (0.05 )     0.2       0.01       (4.7 )     (0.14 )
Total tax adjustments (C)   $ (1.6 )   $ (0.05 )   $ 0.2     $ 0.01     $ (3.8 )   $ (0.11 )
Adjusted net earnings (A+B+C) and Adjusted net earnings per share   $ 70.0     $ 2.22     $ 79.1       2.46     $ 63.0       1.93  
                                     
Net sales   $ 550.4           $ 586.9           $ 512.9        
                                     
Net earnings (loss) as a % of net sales     11.0 %           10.2 %           -8.2 %      
                                     
Adjusted net earnings as a % of net sales     12.7 %           13.5 %           12.3 %      

(a) Reflected in selling, general and administrative and other (expense) income, net.
(b) Reflected in cost of goods sold.
(c) Reflected in restructuring charges.
(d) Reflected in other (expense) income, net.
(e) Reflected in income tax expense (income). For 2021, the discrete tax items relate to items we deemed outside normal cash-generating operations including, $5.4 million of a stranded tax benefit from the U.S. Pension termination offset by $0.7 million of tax expense from tax costs associated with a one-time internal cash movement, and $0.9 million related to the addition of a valuation allowance for a foreign subsidiary. For 2022, the discrete tax items relate to the net impact to tax expense of expired R&D credits, including the release of associated reserves. For 2023, discrete tax items include adjusting for tax benefits resulting from $0.6 million for research and development tax credits from prior years, $0.8 million in foreign tax credits related to prior years from a 2023 tax law change, as well as $0.2m from the release of uncertain tax benefits.
(f) We determine the tax effect of non-GAAP adjustments by considering the tax laws and statutory income tax rates applicable in the tax jurisdictions of the underlying non-GAAP adjustments. For all periods presented, we applied the statutory income tax rates to the taxable portion of all of our adjustments. Our acquisition costs and foreign currency gains and losses included in our non-GAAP adjustments were not deductible for income tax purposes; therefore, no statutory income tax rate was applied to such costs.

NOTE: CTS believes that adjusted gross margin, adjusted operating earnings, adjusted EBITDA margin, adjusted net earnings and adjusted diluted earnings per share provide useful information to investors regarding its operational performance because they enhance an investor’s overall understanding of CTS’ core financial performance and facilitate comparisons to historical results of operations, by excluding items that are not related directly to the underlying performance of CTS’ fundamental business operations (such as those items noted above in the paragraph titled “Non-GAAP Financial Measures”) or were not part of CTS’ business operations during a comparable period.

Controllable Working Capital

    December 31,  
    2023     2022     2021  
Net accounts receivable   $ 78.6     $ 90.9     $ 82.2  
                   
Net inventory   $ 60.0     $ 62.3     $ 49.5  
                   
Accounts payable   $ (43.5 )   $ (53.2 )   $ (55.5 )
                   
Controllable working capital   $ 95.1     $ 100.0     $ 76.2  
                   
Quarter sales   $ 124.7     $ 142.3     $ 132.5  
Multiplied by 4     4       4       4  
Annualized sales   $ 498.8     $ 569.1     $ 530.0  
                   
Controllable working capital as a % of annualized sales     19.1 %     17.6 %     14.4 %

NOTE: CTS believes the controllable working capital ratio is a useful measure because it provides an objective measure of the efficiency with which CTS manages its short-term capital needs.

Free Cash Flow

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Net cash provided by operating activities   $ 32.1     $ 25.5     $ 88.8     $ 121.2     $ 86.1  
Capital expenditures     (3.5 )     (5.1 )     (14.7 )     (14.3 )     (15.6 )
Free cash flow   $ 28.6     $ 20.4     $ 74.1     $ 106.9     $ 70.5  
                               
Operating cash flow as a percentage of net earnings     209 %     170 %     147 %     203 %     -206 %
Free cash flow as a percentage of adjusted net earnings     195 %     115 %     106 %     135 %     112 %

NOTE: CTS believes that free cash flow is a useful measure because it demonstrates the company’s ability to generate cash. Free cash flow is a non-GAAP measure and should be considered in addition to, but not as a substitute for, information contained in the company’s condensed consolidated statement of cash flows as a measure of liquidity.

Capital Expenditures

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Capital expenditures   $ 3.5     $ 5.1     $ 14.7     $ 14.3     $ 15.6  
Net sales   $ 124.7     $ 142.3     $ 550.4     $ 586.9     $ 512.9  
Capex as % of net sales     2.8 %     3.6 %     2.7 %     2.4 %     3.0 %


Additional Information

The following table includes other financial information not presented in the preceding financial statements.

    Three Months Ended
December 31,
    Twelve Months Ended
December 31,
 
    2023     2022     2023     2022     2021  
Depreciation and amortization expense   $ 7.3     $ 8.0     $ 28.7     $ 29.8     $ 26.9  
Stock-based compensation expense   $ 0.5     $ 1.9     $ 5.2     $ 7.7     $ 6.1  

 


Bay Street News